Future studies should leverage publicly available RNAseq datasets to analyze the expression dynamics of PI3K, AKT, 4EBP1, mTOR, and PTEN in primary ALL patient samples treated with decitabine. Here, MTOR is linked to acute lymphoblastic leukemia.